KBC Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $119M | Sell |
242,550
-779
| -0.3% | -$423K | 0.3% | 71 |
|
|
2025
Q4 | $141M | Buy |
243,329
+11,953
| +5% | +$6.76M | 0.32% | 60 |
|
|
2025
Q3 | $112M | Sell |
231,376
-2,549
| -1% | -$1.19M | 0.27% | 78 |
|
|
2025
Q2 | $94.8M | Sell |
233,925
-23,829
| -9% | -$9.96M | 0.26% | 81 |
|
|
2025
Q1 | $128M | Sell |
257,754
-46,047
| -15% | -$24.9M | 0.4% | 52 |
|
|
2024
Q4 | $158M | Sell |
303,801
-72,392
| -19% | -$39.8M | 0.44% | 38 |
|
|
2024
Q3 | $233M | Buy |
376,193
+128,968
| +52% | +$76.3M | 0.7% | 19 |
|
|
2024
Q2 | $137M | Sell |
247,225
-45,918
| -16% | -$26.3M | 0.41% | 42 |
|
|
2024
Q1 | $170M | Sell |
293,143
-174,627
| -37% | -$98M | 0.54% | 31 |
|
|
2023
Q4 | $248M | Sell |
467,770
-30,058
| -6% | -$14.5M | 0.88% | 17 |
|
|
2023
Q3 | $252M | Buy |
497,828
+13,502
| +3% | +$7.19M | 1.03% | 14 |
|
|
2023
Q2 | $253M | Buy |
484,326
+6,404
| +1% | +$3.46M | 1.04% | 14 |
|
|
2023
Q1 | $275M | Sell |
477,922
-93,234
| -16% | -$52.5M | 1.17% | 9 |
|
|
2022
Q4 | $315M | Sell |
571,156
-89,326
| -14% | -$47.3M | 1.53% | 6 |
|
|
2022
Q3 | $335M | Buy |
660,482
+2,558
| +0.4% | +$1.43M | 1.74% | 6 |
|
|
2022
Q2 | $357M | Sell |
657,924
-67,641
| -9% | -$37.2M | 1.78% | 4 |
|
|
2022
Q1 | $429M | Buy |
725,565
+28,252
| +4% | +$16.2M | 1.69% | 6 |
|
|
2021
Q4 | $465M | Buy |
697,313
+241,183
| +53% | +$151M | 1.53% | 7 |
|
|
2021
Q3 | $261M | Sell |
456,130
-384,740
| -46% | -$211M | 0.96% | 15 |
|
|
2021
Q2 | $424M | Buy |
840,870
+72,400
| +9% | +$34.2M | 0.76% | 20 |
|
|
2021
Q1 | $351M | Sell |
768,470
-45,050
| -6% | -$21.5M | 0.71% | 21 |
|
|
2020
Q4 | $1.98B | Buy |
813,520
+180,428
| +28% | +$84.6M | 0.84% | 17 |
|
|
2020
Q3 | $280M | Sell |
633,092
-15,082
| -2% | -$6.23M | 0.83% | 20 |
|
|
2020
Q2 | $235M | Buy |
648,174
+295,528
| +84% | +$99.1M | 0.78% | 26 |
|
|
2020
Q1 | $100M | Sell |
352,646
-122,768
| -26% | -$38.7M | 0.84% | 19 |
|
|
2019
Q4 | $154M | Buy |
475,414
+105,000
| +28% | +$31.8M | 0.98% | 12 |
|
|
2019
Q3 | $108M | Buy |
370,414
+106,217
| +40% | +$30.4M | 0.79% | 20 |
|
|
2019
Q2 | $77.6M | Buy |
264,197
+7,079
| +3% | +$1.95M | 0.6% | 26 |
|
|
2019
Q1 | $70.4M | Buy |
257,118
+25,405
| +11% | +$6.32M | 0.58% | 27 |
|
|
2018
Q4 | $51.9M | Sell |
231,713
-43,380
| -16% | -$10.2M | 0.58% | 32 |
|
|
2018
Q3 | $67.1M | Buy |
275,093
+15,247
| +6% | +$3.51M | 0.51% | 31 |
|
|
2018
Q2 | $53.8M | Buy |
259,846
+9,258
| +4% | +$1.97M | 0.47% | 41 |
|
|
2018
Q1 | $51.7M | Sell |
250,588
-45,020
| -15% | -$9.45M | 0.48% | 42 |
|
|
2017
Q4 | $56.1M | Buy |
295,608
+145,687
| +97% | +$27.9M | 0.48% | 40 |
|
|
2017
Q3 | $28.4M | Sell |
149,921
-15,906
| -10% | -$2.88M | 0.26% | 100 |
|
|
2017
Q2 | $28.9M | Sell |
165,827
-2,426
| -1% | -$407K | 0.28% | 94 |
|
|
2017
Q1 | $25.8M | Sell |
168,253
-49,098
| -23% | -$7.5M | 0.23% | 104 |
|
|
2016
Q4 | $30.7M | Sell |
217,351
-72,679
| -25% | -$10.7M | 0.3% | 71 |
|
|
2016
Q3 | $46.1M | Buy |
290,030
+33,124
| +13% | +$5.1M | 0.55% | 37 |
|
|
2016
Q2 | $38M | Buy |
256,906
+82,853
| +48% | +$12.2M | 0.54% | 31 |
|
|
2016
Q1 | $24.6M | Buy |
174,053
+51,350
| +42% | +$6.88M | 0.41% | 54 |
|
|
2015
Q4 | $17.4M | Buy |
122,703
+56,169
| +84% | +$7.49M | 0.32% | 76 |
|
|
2015
Q3 | $8.14M | Sell |
66,534
-44,403
| -40% | -$5.78M | 0.16% | 160 |
|
|
2015
Q2 | $14.4M | Buy |
110,937
+74,684
| +206% | +$9.74M | 0.19% | 152 |
|
|
2015
Q1 | $4.87M | Sell |
36,253
-28,113
| -44% | -$3.62M | 0.06% | 315 |
|
|
2014
Q4 | $8.06M | Buy |
64,366
+42,422
| +193% | +$5.16M | 0.1% | 250 |
|
|
2014
Q3 | $2.67M | Sell |
21,944
-61,964
| -74% | -$7.53M | 0.09% | 284 |
|
|
2014
Q2 | $9.9M | Buy |
83,908
+13,586
| +19% | +$1.6M | 0.11% | 228 |
|
|
2014
Q1 | $8.46M | Sell |
70,322
-3,439
| -5% | -$409K | 0.13% | 198 |
|
|
2013
Q4 | $8.21M | Buy |
73,761
+7,118
| +11% | +$708K | 0.12% | 220 |
|
|
2013
Q3 | $6.14M | Sell |
66,643
-3,694
| -5% | -$334K | 0.1% | 266 |
|
|
2013
Q2 | $5.95M | Buy |
+70,337
| New | +$5.86M | 0.11% | 243 |
|
Other funds holding TMO
VCM
KBC Group's TMO Position: Q1 2026 in Review
KBC Group reduced its Thermo Fisher Scientific (TMO) stake by 0.32% in Q1 2026, selling an estimated $423K and leaving 242,550 shares worth $119M. The position accounts for 0.3% of the portfolio, ranked #71.
KBC Group first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.98B in Q4 2020. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- KBC Group held 242,550 shares of Thermo Fisher Scientific worth $119M as of Q1 2026.
- KBC Group sold 779 Thermo Fisher Scientific shares in Q1 2026, an estimated $423K.
- Thermo Fisher Scientific made up 0.3% of KBC Group's portfolio in Q1 2026, its #71 holding.
- KBC Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- KBC Group's Thermo Fisher Scientific position peaked at $1.98B in Q4 2020.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.